OptimizeRx (OPRX) Total Liabilities (2010 - 2026)

OptimizeRx has disclosed Total Liabilities across 17 years of filings, most recently posting $33.2 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 33.5% year-over-year to $33.2 million; the TTM figure through Jun 2026 stood at $33.2 million (down 33.5% YoY), while the FY2025 annual figure was $48.6 million, down 10.24% from the prior year.
• Total Liabilities came in at $33.2 million for Q2 2026 at OptimizeRx, down from $37.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $56.8 million in Q4 2023 to a low of $5.5 million in Q2 2023.
• Average Total Liabilities over 5 years is $32.6 million, with a median of $42.9 million recorded in 2025.
• Year-over-year, Total Liabilities soared 841.25% in 2024 and slumped 33.5% in 2026.
• Over 5 years, Total Liabilities stood at $8.5 million in 2022, then surged by 565.32% to $56.8 million in 2023, then dropped by 4.67% to $54.2 million in 2024, then slipped by 10.24% to $48.6 million in 2025, then tumbled by 31.65% to $33.2 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $33.2 million in Q2 2026, $37.7 million in Q1 2026, and $48.6 million in Q4 2025.